Cellebrite DI Ltd.
Cellebrite DI Ltd. Q4 FY2025 earnings call
February 11, 2026 · fiscal period ended 2025-12
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-02-11
Management highlights
- Cemented insights offering as the gold standard in digital forensics.
- Drove strong adoption of SaaS and cloud-based offerings, with ARR for these offerings growing north of 50% and representing 22% of total ARR.
- Extended integrated AI functionality, completed acquisition of Keryllium, and added talent.
- Converted 55% of installed digital forensics space to Insights, exceeding the 50% target.
- Doubled down on mobile research to maintain leadership in Android and reassert leadership in iOS, with new capabilities expected in the coming six weeks.
- Completed acquisition of Keryllium, with its ARM virtualization technology seen as a unique asset.
- Announced agreement to purchase SCG Canada to address drone forensics, expected to close by end of first quarter.
- Progress in ethical use of GenAI, with AI viewed as a tailwind across internal productivity, user productivity, and monetization of agentic applications.
Segment performance
ARR grew 21% to $481 million in 2025, including the acquisition of Keryllium. Excluding Keryllium, ARR grew 17% year over year. Geographically, The Americas represented 53% of total ARR, EMEA 35%, and Asia Pacific 12%. Q4 revenue was $128.8 million, full year revenue $475.7 million. Software solutions drove approximately 90% of total revenue. Q4 gross profit was $110.8 million (86% gross margin), full year gross margin 85%. Q4 adjusted EBITDA was $38.3 million (33% increase from prior year), full year adjusted EBITDA $127.6 million (26.8% margin).
Guidance
- 2026 ARR guidance: 18% to 19% growth, range $567-573 million.
- 2026 revenue guidance: 19% to 20% growth, range $565-571 million.
- 2026 adjusted EBITDA guidance: $149-155 million, 26%-27% margin.
- First quarter 2026 ARR expected: $491-493 million (20-21% growth), revenue $127-129 million, adjusted EBITDA $26-28 million (21-22% margin).
Risks
- FX headwinds due to shekel strengthening against the US dollar.
- Integration risks associated with acquisitions such as Keryllium and SCG Canada.
Q&A highlights
Q: Congrats on solid year and a strong '26 guide. Maybe first on the acquisitions. I mean, kind of announced SCG Canada expecting to close kind of two deals in quick succession...
A: Thomas E. Hogan states SCG Canada is a small, market-leading drone forensic solution, with good spacing between acquisitions and low complexity.
Q: Hi, good morning, and let me echo my congratulations as well. I wanted to start out with maybe a little bit more color on the investments that you made to extend your mobile forensics leadership...
A: Thomas E. Hogan explains investments in internal research and partnerships to maintain leadership in Android and iOS, expected to drive growth in unlock access and insights.
Q: And then just in terms of your comments around the U.S. Federal government spending environment...
A: Marcus Jewell discusses pent-up demand in defense, intelligence, border security, and upcoming events like the FIFA World Cup, citing confidence in growth due to macro use cases and multi-year budgets.
Q: Thank you. Good good afternoon, everybody. Congrats on solid 2025 completion. Tom, maybe just for clarification, I've been getting some emails from investors...
A: Thomas E. Hogan clarifies SCG Canada has a low single-digit ARR run rate, price paid in $15-20 million range, and strong growth potential.
Q: Great. Thanks for taking the questions. Congrats on that free cash flow margin in particular. Tom, on the AI side...
A: Thomas E. Hogan talks about AI driving productivity, innovation center developing agentic applications, and monetization efforts in progress.
Q: Great. Thanks for taking the questions here, guys, and I'll echo the congratulations on the strong finish to the year. I wanted to come back to the insights conversions and the unlocks for a second...
A: David Barter explains insights conversions follow deal seasonality and unlocks will ramp from Q2, with visibility into these areas informing guidance.
Q: Great. Thank you for taking the question. And congrats on the results. Great to see the stabilization, particularly in the Fed. Maybe, Dan, if I could if I could maybe have you unpack a little bit of the commentary you had on the guidance...
A: David Barter discusses tighter ARR and revenue ranges due to improved forecast accuracy and reliance on customer base motion and expirations.
Q: Yes, Tom, I wanted to dive a layer deeper on your comments regarding AI. Curious to know, in your conversations with customers...
A: Thomas E. Hogan explains AI is a tailwind for Cellebrite due to unique data intimacy and domain expertise, with AI enhancing forensic capabilities and customer adoption.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.14 | $0.14 | +0.0% | $0.10 |
| Revenue | $128.8M | $127.0M | +1.4% | $109.0M |
Transcript
February 11, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.